Vyndaqel

Tafamidis Meglumine

8.2 High risk

Vyndaqel & Death

28.2%

of users reported Death

91.6%

also reported Death

83.9%

are men

Most common medical consequences

Death

91.6%

Severe reaction

6.7%

Hospitalization

1.7%

Have you experienced any negative side effects from this medication?

Vyndaqel: general information

Most common side effects (51)

Most commonly affected ages

60 - 69 years

9.1%

70 - 79 years

37.5%

80 - 89 years

47.2%

90 - 99 years

6.2%